ChartRow logo
Data provided bySource: Twelve Data
PeersBDXALCRMDISRGSOLVCOO
Share this page

MDLN — Medline Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data

Price data

Price
$39.47
YTD price return
-6.02%
YTD total return
-6.02%
Market cap
51.9B
Enterprise value
69B
Shares outstanding
1.3B
52W low
$31.37
52W high
$50.88
From 52W high
-22.42%
From 52W low
+25.82%
52W range
42%$31.37–$50.88

Volume

Rel volume
0.88×
30D volume
9.6M
30D $ vol
346.4M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$996.4M
Insider net 1Y
−$12.35B

Form 4 transactions by trade date, as filed; latest on file 2026-10-08.

Fundamentals

Sales (ttm)
30.7B
Sales/share
$23.31
EPS (ttm)
$0.44
FCF (ttm)
1.9B
FCF/share
$1.44
Book value/share
$8.97
Net margin
1.88%
ROE
4.89%
ROA
1.44%
Debt / equity
1.06×
Current ratio
4.04

Growth (CAGR, ttm) · 10Y

Sales
n/a+10.69%n/an/a
Net income
n/a+39.05%n/an/a
FCF
n/a+11.40%n/an/a

Per-share growth (CAGR, ttm) · 10Y

Price
-4.11%n/an/an/a
Total return
-4.11%n/an/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
90.0×
Fwd P/E
25.4×
P/S (ttm)
1.7×
P/B (mrq)
4.4×
P/FCF (ttm)
27.4×
EV/EBITDA (fy)
24.9×
EV/Sales (ttm)
2.2×
FCF yield (ttm)
3.65%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Performance · price returntotal return · as of 2026-11-13#

Data provided bySource: Twelve Data
1D
-1.28%
5D
-0.43%
1M
+10.56%
3M
+10.93%
YTD
-6.02%
1Y
—
5Y
—
1D
-1.28%
5D
-0.43%
1M
+10.56%
3M
+10.93%
YTD
-6.02%
1Y
—
5Y
—

Fundamentals#

Revenue

YoY +10.4%
$30.7B TTM$7.9B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

YoY −12.9%
$1.7B TTM$500M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

YoY −38.7%
$577M TTM$195M Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

YoY +65.2%
$1.9B TTM$884M Q3 '26
FY23FY24FY25TTM

TTM: operating cash flow $2.4B, capex −$486M

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $1B, capex −$141M

Gross profit

YoY +2.7%
$7.9B TTM$1.9B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

YoY +61.2%
$2.4B TTM$1B Q3 '26
FY23FY24FY25TTM
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full MDLN financials →

Medline Inc. Class A Common Stock represents ownership in Medline Inc., a healthcare company focused on medical-surgical products and supply chain solutions. Medline serves hospitals, ambulatory surgery centers, physician offices, post-acute facilities, and nursing homes through a broad portfolio of products and services used across everyday clinical care. Its business is organized around product manufacturing and procurement, as well as logistics and distribution support for healthcare customers. The company also provides tailored supply chain solutions designed to help healthcare providers manage sourcing, inventory, and delivery across multiple care settings. Medline’s role in the market is centered on supporting the operational needs of the healthcare industry with essential supplies and integrated services.

Northfield, IL·45,000 employees·Medical Instruments & Supplies·medline.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding MDLN#

21 of the 193 ETFs ChartRow carries live hold MDLN. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VOEVanguard Mid-Cap Value ETF0.3%
VXFVanguard Extended Market ETF0.2%
VHTVanguard Health Care ETF0.2%
IWSiShares Russell Mid-Cap Value ETF0.2%
VOVanguard Mid-Cap ETF0.1%
IWRiShares Russell Midcap ETF0.1%
ONEQFidelity Nasdaq Composite Index ETF0.1%
VTVVanguard Value ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+23.75%+1.14%
JNJJohnson & Johnson+14.94%+0.79%
ABBVAbbVie Inc.+7.53%+0.20%
UNHUnitedHealth Group Incorporated Common Stock (DE)+7.86%+0.58%
MRKMerck & Co. Inc.+4.07%+0.55%
NVSNovartis AG+12.70%+0.16%
TMOThermo Fisher Scientific Inc.+5.61%+0.11%
AMGNAmgen Inc.+12.80%-0.30%